Table 3.

Sensitivity analysis of the association between LDL-C level and mortality by censoring time for loss-to-follow-up.

Cut-off	Censoring time	HR(95%CI) (adjusted with final model) ^†
Cut-off	Censoring time	Men	Women	Total
LDL-C≥3.37mmol/L (130mg/dL)	Censoring at 38 months	0.41(0.12–1.34)	0.59(0.35–0.98)^*	0.60(0.37–0.958)^*
	Censoring at 19 months	0.40(0.12–1.31)	0.63(0.38–1.0)	0.62(0.39–0.99)^*
	Deleting all lost-to-follow-up	0.40(0.12–1.32)	0.66(0.40–1.11)	0.64(0.40–1.03)
LDL-C≥3.12mmol/L (120mg/dL )	Censoring at 38 months	0.43(0.15–1.21)	0.57(0.38–0.85) ^**	0.59(0.41–0.85) ^**
	Censoring at 19 months	0.41(0.15–1.17)	0.57(0.38–0.85) ^**	0.59(0.41–0.85) ^**
	Deleting all lost-to-follow-up	0.41(0.15–1.16)	0.58(0.39–0.87) ^**	0.59(0.41–0.86) ^**
LDL-C≥2.85mmol/L (110mg/dL)	Censoring at 38 months	0.67(0.35–1.29)	0.69(0.51–0.94)^*	0.72(0.55–0.95)^*
	Censoring at 19 months	0.69(0.36–1.34)	0.67(0.50–0.92)^*	0.71(0.54–0.94)^*
	Deleting all lost-to-follow-up	0.71(0.37–1.38)	0.68(0.50–0.92)^*	0.72(0.54–0.94)^*
Each 1 mmol/L increase in LDL-C	Censoring at 38 months	0.71(0.53–0.96)^*	0.80(0.69–0.93) ^**	0.81(0.71–0.92) ^**
	Censoring at 19 months	0.73(0.54–0.98)^*	0.80(0.69–0.93) ^**	0.82(0.71–0.93) ^**
	Deleting all lost-to-follow-up	0.74(0.56–0.99)^*	0.81(0.69–0.94) ^**	0.82(0.72–0.94)^*

Abbreviations: LDL-C=low-density lipoprotein cholesterol;

P<0.05,

^**

P<0.01.

^†

Adjusted for sex, age, marital status, current smoking, current alcohol drinking, tea drinking, central obesity, cognitive impairment, ADL restriction, blindness, chronic kidney disease, anemia, hypertension, type 2 diabetes mellitus and abnormal HDL-C level.